Non-invasive assessment of liver abnormalities in pediatric Fontan patients-Reference-Cited by-同舟云学术

Non-invasive assessment of liver abnormalities in pediatric Fontan patients

Published:2021-07-06 Issue:1 Volume:181 Page:159-169
ISSN:0340-6199
Container-title:European Journal of Pediatrics
language:en
Short-container-title:Eur J Pediatr

Author:

De Bruyne Ruth^ORCID,Vandekerckhove Kristof,Van Overschelde Hazel,Hendricx Fabian,Vande Walle Caroline,De Groote Katya,Panzer Joseph,De Wolf Daniel,Van Biervliet Stephanie,Bové Thierry,François Katrien

Publisher

Springer Science and Business Media LLC

Subject

Pediatrics, Perinatology and Child Health

Link

https://link.springer.com/content/pdf/10.1007/s00431-021-04163-3.pdf

Reference37 articles.

1. Tomkiewicz-Pajak LOM, Komnata K et al (2014) Lung function and exercise tolerance in adults after Fontan procedure. Exp Clin Cardiol 20:2606–2614

2. Rychik JGD, Rand E et al (2013) End-organ consequences of the Fontan operation: liver fibrosis, protein-losing enteropathy and plastic bronchitis. Cardiol Young 23:831–840

3. Ghaferi AA, Hutchins GM (2005) Progression of liver pathology in patients undergoing the Fontan procedure: Chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg 129:1348–1352

4. Gewillig M, Brown SC (2016) The Fontan circulation after 45 years: update in physiology. Heart 102:1081–1086

5. Rychik J (2016) The relentless effects of the Fontan paradox. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 19:37–43

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytokeratin-18 is Elevated Prior to Conventional Measures of Liver Disease in Fontan-Associated Liver Disease;Pediatric Cardiology;2024-09-05

2. Prognostic Indicators of Morbidity and Mortality in Children with Congestive Hepatopathy Presenting with Ascites;Diagnostics;2024-07-26

3. Importance of gamma‐glutamyl transferase elevation in patients with Fontan‐associated liver disease;Hepatology Research;2024-07-10

4. Meta‐analysis: Incidence of cirrhosis and hepatocellular carcinoma in patients with Fontan palliation;Alimentary Pharmacology & Therapeutics;2024-03-18

5. Fontan-Associated Liver Disease: A Review;Cardiology in Review;2024-03-13